What is the Return on Assets (ROA) of Verastem this year?
The Return on Assets (ROA) of Verastem is -0.58 undefined this year.
Verastem ROA 2024
Verastem ROA
-0.58
Ticker
VSTM
ISIN
US92337C1045
WKN
A1JTPU
In 2024, Verastem's return on assets (ROA) was -0.58, a -24.81% increase from the -0.78 ROA in the previous year.
Verastem Aktienanalyse
What does Verastem do?
Verastem Inc. is a biopharmaceutical company founded by Dr. Christoph Westphal in Cambridge, Massachusetts, in 2010. The company focuses on developing drugs for the treatment of cancer and other serious diseases using technologies based on small molecules and RNA interference. The company specializes in developing therapies for patients with particularly aggressive types of cancer, such as diffuse large B-cell lymphoma (DLBCL), mesothelial tumors, liver cancer, and pancreatic cancer. Verastem collaborates closely with leading academic research institutions and clinics around the world to test and validate the efficacy and safety of its therapies. Verastem's business model is based on identifying and developing drug candidates based on the needs of patients with serious diseases. The company uses patented screening technologies to identify compounds that selectively target specific cancer cells without harming healthy cells. These compounds are then tested in preclinical and clinical studies to demonstrate their efficacy and safety for use in humans. One of Verastem's main areas of focus is the development of drugs that target signaling pathways in cancer cells. The company has several drugs in its pipeline that aim to inhibit proteins that are central to the growth and survival of cancer cells. These include VS-6063, VS-5584, and VS-5095. VS-6063 is a small molecule that targets the inhibition of the Focal Adhesion Kinase (FAK) protein. FAK plays a key role in the development and progression of cancer by promoting the growth and movement of cancer cells. VS-6063 is currently being studied in clinical trials for the treatment of mesothelioma, pancreatic cancer, and other types of cancer. VS-5584 is a small molecule that targets the inhibition of the mammalian Target of Rapamycin (mTOR) protein. mTOR is an important regulator of cell growth and division that is overactive in many types of cancer. VS-5584 is currently being studied in clinical trials for the treatment of liver cancer and other types of cancer. VS-5095 is a small molecule that targets the inhibition of the Wnt protein, which plays a crucial role in regulating cell proliferation and differentiation. Wnt is also involved in the development of cancer as it can contribute to the transformation of normal cells into cancer cells. VS-5095 is currently in preclinical studies for the treatment of various types of cancer. Verastem also has a promising pipeline of RNA interference therapies that aim to inhibit the expression of specific genes in cancer cells. One such therapy currently in clinical testing, VS-6061, targets the inhibition of the KRAS gene, which is mutated in many types of cancer and can promote the survival and growth of cancer cells. Overall, Verastem aims to develop drugs that are better tailored to the individual needs of patients and help them fight their disease. With its innovative research approach and strong pipeline of drug candidates, the company has the potential to fundamentally change the way cancer is treated. Verastem ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Verastem's Return on Assets (ROA)
Verastem's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Verastem's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Verastem's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Verastem’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Verastem stock
What was the ROA of Verastem compared to the previous year?
The ROA of Verastem has increased by -24.81% compared to the previous year.
What consequences do high ROA have for investors of Verastem?
A high ROA is advantageous for investors of Verastem, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Verastem?
A low ROA can be unfavorable for investors of Verastem as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Verastem affect the company?
An increase in ROA of Verastem can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Verastem impact the company?
A reduction in the ROA of Verastem can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Verastem?
Some factors that can influence the ROA of Verastem include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Verastem important for investors?
The ROA of Verastem is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Verastem take to improve ROA?
To improve ROA, Verastem can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Verastem pay?
Over the past 12 months, Verastem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Verastem is expected to pay a dividend of 0 USD.
What is the dividend yield of Verastem?
The current dividend yield of Verastem is .
When does Verastem pay dividends?
Verastem pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Verastem?
Verastem paid dividends every year for the past 0 years.
What is the dividend of Verastem?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Verastem located?
Verastem is assigned to the 'Health' sector.
Wann musste ich die Aktien von Verastem kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Verastem from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.
When did Verastem pay the last dividend?
The last dividend was paid out on 10/6/2024.
What was the dividend of Verastem in the year 2023?
In the year 2023, Verastem distributed 0 USD as dividends.
In which currency does Verastem pay out the dividend?
The dividends of Verastem are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Verastem
Our stock analysis for Verastem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Verastem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
